OLFM2 and metabolic dysfunction-associated steatohepatitis: Thus, this correlation was consistent with the association with OLFM2 mRNA expression in VAT, and we found decreased expression of this molecule in VAT in NASH, which would decrease adiponectin levels; however, in our subjects, we did not find significant differences in adiponectin, probably due to the abovementioned low-grade chronic inflammation [34].